121 results match your criteria: "University of Florida Shands Cancer Center[Affiliation]"
Blood
April 2013
Department of Medicine, Division of Hematology and Oncology and the University of Florida Shands Cancer Center, Gainesville, FL 32610, USA.
Protein kinase R (PKR) is an interferon (IFN)-inducible, double-stranded RNA-activated kinase that initiates apoptosis in response to cellular stress. To determine the role of PKR in hematopoiesis, we developed transgenic mouse models that express either human PKR (TgPKR) or a dominant-negative PKR (TgDNPKR) mutant specifically in hematopoietic tissues. Significantly, peripheral blood counts from TgPKR mice decrease with age in association with dysplastic marrow changes.
View Article and Find Full Text PDFMethods Enzymol
December 2012
Department of Biochemistry and Molecular Biology, University of Florida Shands Cancer Center Program in Cancer Genetics, Epigenetics, and Tumor Virology, Gainesville, Florida, USA.
A single-molecule probe of chromatin structure can uncover dynamic chromatin states and rare epigenetic variants of biological importance that bulk measures of chromatin structure miss. In bisulfite genomic sequencing, each sequenced clone records the methylation status of multiple sites on an individual molecule of DNA. An exogenous DNA methyltransferase can thus be used to image nucleosomes and other protein-DNA complexes.
View Article and Find Full Text PDFJ Oncol Pract
November 2011
H. Lee Moffitt Cancer Center and Research Institute, Tampa; Center for Cancer Care and Research, Lakeland; Florida Cancer Specialists, Sarasota; Space Coast Medical Associates, Titusville; Ocala Oncology Center, Ocala; Robert and Carol Weissman Cancer Center at Martin Memorial, Stuart; Mayo Clinic, Jacksonville; Cancer Centers of Florida, Orlando; North Broward Medical Center, Deerfield Beach; Tallahassee Memorial Healthcare, Tallahassee; University of Florida/Shands Cancer Center, Gainesville, FL; Karmanos Cancer Institute, Detroit, MI.
Background: Limited data on the quality of care in non-small-cell lung cancer (NSCLC) are available. This study aims to assess the quality of care in NSCLC among 11 medical oncology practices in Florida and to explore the impact of practice volume on care.
Methods: Clinical guidelines and existing indicators were reviewed, and an expert survey was conducted to identify a set of process-based quality of care indicators (QI).
J Med Case Rep
January 2012
Division of Hematology and Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida, Gainesville, FL, USA.
Introduction: Chondrosarcoma is well-known to be primarily resistant to conventional radiation and chemotherapy.
Case Presentation: We present the case of a 32-year-old Caucasian man with clear cell chondrosarcoma who presented with symptomatic recurrence in his pelvis and metastases to his skull and lungs. Our patient underwent systemic therapy with sunitinib and then consolidation with proton beam radiation to his symptomatic site.
Cell Cycle
February 2012
Department of Anatomy and Cell Biology, University of Florida Shands Cancer Center, University of Florida College of Medicine, Gainesville, FL, USA.
Successful viral replication entails elimination or bypass of host antiviral mechanisms. Here, we show that shRNA-mediated knockdown of murine double minute (Mdm2) and its paralog Mdm4 enhanced the expression of early and late viral gene products during adenovirus (HAdV) infection. Remarkably, whereas the expression of HAdV genes was low in p53-deficient mouse embryonic fibroblasts (p53KO MEFs), the HAdV early gene products were efficiently expressed in Mdm2/p53 double-knockout (DKO) and Mdm4/p53 DKO MEFs, and viral capsid proteins were produced in Mdm2/p53 DKO MEFs.
View Article and Find Full Text PDFAsian J Androl
March 2012
Department of Radiation Oncology, University of Florida Shands Cancer Center, Gainesville, FL 32610, USA.
Oncology
April 2012
Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida, Gainesville, FL, USA.
Antiangiogenic therapy has shown promise in the treatment of patients with renal cell carcinoma (RCC). Two classes of antiangiogenic drugs, the anti-vascular endothelial growth factor antibody bevacizumab and the tyrosine kinase inhibitors sorafenib, sunitinib and pazopanib, have shown efficacy in patients with RCC and are approved by the US Food and Drug Administration for treatment of this cancer. In practice, the clinical benefit of antiangiogenic drugs in RCC has been heterogeneous, and in patients who do respond, benefits are modest and/or short-lived.
View Article and Find Full Text PDFJ Oncol Pract
July 2011
H. Lee Moffitt Cancer Center and Research Institute and University of South Florida, Tampa; Center for Cancer Care and Research/Watson Clinic, Lakeland; Florida Cancer Specialists/Sarasota Memorial Hospital, Sarasota; Space Coast Medical Associates, Titusville; Ocala Oncology Center, Ocala; Robert and Carol Weissman Cancer Center at Martin Memorial, Stuart; Mayo Clinic, Jacksonville; Florida Institute of Research, Medicine and Surgery, Orlando; North Broward Medical Center, Deerfield Beach; Tallahassee Memorial Healthcare, Tallahassee; University of Florida/Shands Cancer Center, Gainesville, FL.
Purpose: The Florida Initiative for Quality Cancer Care (FIQCC) comprises 11 Florida practice sites that participate in comprehensive reviews of quality of care specific to patients with cancer. Here, we examined site adherence to performance indicators to assess quality of care for patients with breast cancer (BC).
Methods: Quality indicators were scripted on the basis of accepted guidelines from the Quality Oncology Practice Initiative, National Comprehensive Cancer Network, American College of Surgeons, and site-specific expert panel consensus.
Oncol Rev
September 2011
Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA.
Antiangiogenic therapy has shown promise in the treatment of patients with hepatocellular carcinoma (HCC). Bevacizumab, sorafenib, and sunitinib showed efficacy in patients with HCC; and sorafenib is approved by the FDA for treatment of this cancer. In practice, the clinical benefit of these agents has been heterogeneous; and in patients who do respond, the benefit is modest and/or short-lived.
View Article and Find Full Text PDFOncogene
January 2012
Department of Anatomy and Cell Biology, University of Florida Shands Cancer Center, Gainesville, FL 32610, USA.
Current theories suggest that mitotic checkpoint proteins are essential for proper cellular response to taxanes, a widely used family of chemotherapeutic compounds. We recently showed that absence or depletion of protein Daxx increases cellular taxol (paclitaxel) resistance-a common trait of patients diagnosed with several malignancies, including breast cancer. Further investigation of Daxx-mediated taxol response revealed that Daxx is important for the proper timing of mitosis progression and cyclin B stability.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
October 2011
Department of Radiation Oncology, University of Florida Shands Cancer Center, Gainesville, FL 32610, USA.
Purpose: Intratumoral hypoxia is known to be associated with radioresistance and metastasis. The present study examined the effect of acute and chronic hypoxia on the metastatic potential of prostate cancer PC-3, DU145, and LNCaP cells.
Methods And Materials: Cell proliferation and clonogenicity were tested by MTT assay and colony formation assay, respectively.
Methods Mol Biol
July 2011
Department of Molecular Genetics and Microbiology, University of Florida Shands Cancer Center, University of Florida, Gainesville, FL, USA.
Since 2004, more than 200 microRNAs (miRNAs) have been discovered in double-stranded DNA viruses, mainly herpesviruses and polyomaviruses (Nucleic Acids Res 32:D109-D111, 2004). miRNAs are short 22 ± 3 nt RNA molecules that posttranscriptionally regulate gene expression by binding to 3'-untranslated regions (3'UTR) of target mRNAs, thereby inducing translational silencing and/or transcript degradation (Nature 431:350-355, 2004; Cell 116:281-297, 2004). Since miRNAs require only limited complementarity for binding, miRNA targets are difficult to determine (Mol Cell 27:91-105, 2007).
View Article and Find Full Text PDFJ Biol Chem
March 2011
Department of Anatomy and Cell Biology, University of Florida Shands Cancer Center, University of Florida, Gainesville, Florida 32610, USA.
Although histone deacetylases (HDACs) are normally considered as co-repressors, HDAC1 has been identified as a coactivator for the glucocorticoid receptor (GR) (Qiu, Y., Zhao, Y., Becker, M.
View Article and Find Full Text PDFNucleic Acids Res
January 2011
Department of Biochemistry and Molecular Biology, University of Florida Shands Cancer Center Program in Cancer Genetics, Epigenetics and Tumor Virology, Gainesville, FL 32610-3633, USA.
Bisulfite sequencing is a widely-used technique for examining cytosine DNA methylation at nucleotide resolution along single DNA strands. Probing with cytosine DNA methyltransferases followed by bisulfite sequencing (MAPit) is an effective technique for mapping protein-DNA interactions. Here, MAPit methylation footprinting with M.
View Article and Find Full Text PDFMed Hypotheses
February 2011
Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida, Gainesville, FL 32610-0278, United States.
Cancer cells undergo significant metabolic adaptation. Cellular transformation enhances both glycolysis and mitochondrial respiration efficiency through the induction of HIF-1α and HIF-2α. In this process, energy production and synthesis of macromolecules are maximized with minimal ROS accumulation.
View Article and Find Full Text PDFBiol Blood Marrow Transplant
March 2010
University of Florida Shands Cancer Center, Gainesville, FL, USA.
J Natl Cancer Inst
February 2010
University of Florida Shands Cancer Center, Department of Medicine, University of Florida, Gainesville, FL 32610, USA.
Objective: To provide health-care providers, patients, and the general public with a responsible assessment of currently available data on the diagnosis and management of ductal carcinoma in situ (DCIS).
Participants: A non-Department of Health and Human Services, nonadvocate, 14-member panel representing the fields of oncology, radiology, surgery (general and reconstructive), pathology, radiation oncology, internal medicine, epidemiology, biostatistics, nursing, obstetrics and gynecology, preventative medicine and population health, and social work. In addition, 22 experts from pertinent fields presented data to the panel and conference audience.
Mol Cancer Res
December 2009
Department of Anatomy and Cell Biology and University of Florida Shands Cancer Center, University of Florida, Gainesville, FL 32610, USA.
The recent emerging concept to sensitize cancer cells to DNA-alkylating drugs is by inhibiting various proteins in the base excision repair (BER) pathway. In the present study, we used structure-based molecular docking of DNA polymerase beta (Pol-beta) and identified a potent small molecular weight inhibitor, NSC-666715. We determined the specificity of this small molecular weight inhibitor for Pol-beta by using in vitro activities of APE1, Fen1, DNA ligase I, and Pol-beta-directed single-nucleotide and long-patch BER.
View Article and Find Full Text PDFJ Oncol Pract
November 2009
University of Florida Shands Cancer Center, Gainesville, FL.
In 2002, the ASCO Board of Directors reviewed a proposal for a new approach to promoting high-quality cancer care. Today, the Quality Oncology Practice Initiative has 500 participating practices that report data on approximately 35,000 medical records annually.
View Article and Find Full Text PDFNIH Consens State Sci Statements
September 2009
University of Florida Shands Cancer Center, University of Florida, Gainesville, Florida, USA.
Objective: To provide health care providers, patients, and the general public with a responsible assessment of currently available data on the diagnosis and management of ductal carcinoma in situ (DCIS).
Participants: An non-DHHS, nonadvocate 14-member panel representing the fields of fields of oncology, radiology, surgery (general and reconstructive), pathology, radiation oncology, internal medicine, epidemiology, biostatistics, nursing, obstetrics and gynecology, preventative medicine and population health, and social work. In addition, 22 experts from pertinent fields presented data to the panel and conference audience.
J Virol
November 2009
Division of Infectious Diseases, Department of Medicine, and University of Florida Shands Cancer Center, University of Florida, Gainesville, Florida, USA.
Epstein-Barr virus (EBV) SM protein is an essential nuclear shuttling protein expressed by EBV early during the lytic phase of replication. SM acts to increase EBV lytic gene expression by binding EBV mRNAs and enhancing accumulation of the majority of EBV lytic cycle mRNAs. SM increases target mRNA stability and nuclear export, in addition to modulating RNA splicing.
View Article and Find Full Text PDFMol Cell Biol
September 2009
Department of Biochemistry and Molecular Biology and University of Florida Shands Cancer Center, University of Florida College of Medicine, Gainesville, FL 32610-3633, USA.
Cells devote considerable resources to nutrient homeostasis, involving nutrient surveillance, acquisition, and storage at physiologically relevant concentrations. Many Saccharomyces cerevisiae transcripts coding for proteins with nutrient uptake functions exhibit peak periodic accumulation during M phase, indicating that an important aspect of nutrient homeostasis involves transcriptional regulation. Inorganic phosphate is a central macronutrient that we have previously shown oscillates inversely with mitotic activation of PHO5.
View Article and Find Full Text PDFLancet Oncol
June 2009
University of Florida Shands Cancer Center, PO Box 103633, Gainesville, FL 32610, USA.
Gene
September 2009
Department of Internal Medicine, University of Florida Shands Cancer Center, P.O. Box No: 103633, Gainesville, FL 32610, USA.
Tnk1/Kos1 is a non-receptor protein tyrosine kinase found to be a tumor suppressor. It negatively regulates cell growth by indirectly suppressing Ras activity. We identified and characterized the critical cis-elements required for Tnk1/Kos1's promoter activity.
View Article and Find Full Text PDFMol Carcinog
November 2009
University of Florida Shands Cancer Center, Gainesville, Florida, USA.
The NF1 gene that is altered in patients with type 1 neurofibromatosis (NF1) encodes a neurofibromin protein that functions as a tumor suppressor. In this report, we show for the first time physical interaction between neurofibromin and focal adhesion kinase (FAK), the protein that localizes at focal adhesions. We show that neurofibromin associates with the N-terminal domain of FAK, and that the C-terminal domain of neurofibromin directly interacts with FAK.
View Article and Find Full Text PDF